文献速递创伤骨科骨质疏松与代谢性骨病

标准化护理路径下白人与非白人髋部骨折术后患者护理质量指标、并发症及死亡无差异

No Differences Between White and Non-White Patients in Terms of Care Quality Metrics, Complications, and Death After Hip Fracture Surgery When Standardized Care Pathways Are Used.
PubMed 文献 · Clin Orthop Relat Res · 2022-03-01

该回顾性比较研究纳入2014年10月至2020年3月在城市学术医疗系统四所医院(含骨科三级医院)接受标准化4天髋部骨折路径治疗的1824例55岁及以上低能量髋部骨折患者,分析1111例白人与427例非白人患者。控制性别、保险、社会经济状态和STTGMA创伤风险评分后,非白人种族与住院、30天及1年死亡率无关联,与手术延迟超过2天无关联,与ICU入住率较低和主要并发症较少相关。作者鼓励外科医生定制并在本机构试用该路径,未来研究应使用STTGMA评分作为控制混杂因素或开展随机试验。

要点

  • 标准化髋部骨折路径下,非白人种族与住院、30天及1年死亡率无显著关联。
  • 非白人种族与ICU入住较少(OR 0.6)和主要并发症较少(OR 0.5)相关。
  • STTGMA创伤风险评分与所有终点相关。

核心结论

  • 在减少从就诊到出院变异的髋部骨折护理路径背景下,控制包括创伤风险评分在内的基线差异后,白人与非白人患者在死亡率、手术时间、并发症和出院去向率方面未观察到差异。
  • 作者鼓励外科医生定制该路径并在本机构试用,以提供公平护理并减少医疗差异。
  • 未来研究应通过使用STTGMA创伤风险评分作为控制混杂因素或随机试验比较标准化与个体化外科医生特异性护理。

研究设计与样本

  • 回顾性比较研究,评估2014年10月标准化路径启动至2020年3月期间在城市学术医疗系统四所医院(含骨科三级医院)治疗的1824例55岁及以上低能量髋部骨折患者记录。
  • 标准化4天髋部骨折路径包括所有患者内科共管,并明确医生、护理、社会工作、护理管理者及物理和职业治疗从入院至术后第4天预期出院的职责。
  • 1824例中98%(1787/1824)电子病历记录种族者可能合格;14%(249/1787)因无州内地址被排除;纳入者中5%(70/1538)30天失访,22%(336/1538)1年失访。
  • 白人队列为所有选择白人作为主要种族者1111例,非白人队列为所有其他患者427例;白人组72%(801)女性,平均年龄82±10岁;非白人组64%(271)女性,平均年龄80±11岁。
  • 采用单因素卡方和Mann-Whitney U检验比较人口学特征,多变量回归分析控制组间基线差异。

主要发现

  • 非白人种族与住院死亡率无关联(OR 1.1 [95%CI 0.40至2.73];p>0.99)。
  • 非白人种族与30天死亡率无关联(OR 1.0 [95%CI 0.48至1.83];p>0.99)。
  • 非白人种族与1年死亡率无关联(OR 0.9 [95%CI 0.57至1.33];p>0.99)。
  • 非白人种族与手术延迟超过2天无关联(OR 1.1 [95%CI 0.79至1.38];p>0.99)。
  • 非白人种族与ICU入住较少相关(OR 0.6 [95%CI 0.42至0.85];p=0.03)。

关键数值与推荐

  • 非白人种族与住院死亡率无关联:OR 1.1(95%CI 0.40至2.73),p>0.99。
  • 非白人种族与30天死亡率无关联:OR 1.0(95%CI 0.48至1.83),p>0.99。
  • 非白人种族与1年死亡率无关联:OR 0.9(95%CI 0.57至1.33),p>0.99。
  • 非白人种族与手术延迟超过2天无关联:OR 1.1(95%CI 0.79至1.38),p>0.99。
  • 非白人种族与ICU入住较少相关:OR 0.6(95%CI 0.42至0.85),p=0.03;与主要并发症较少相关:OR 0.5(95%CI 0.35至0.83),p=0.047。

临床怎么用

  • 作者鼓励外科医生定制本研究所详述的路径并在本机构试用,目标是为髋部骨折患者提供公平护理并减少医疗差异。
  • 未来研究应通过使用STTGMA创伤风险评分作为控制混杂因素或随机试验比较标准化与个体化外科医生特异性护理。

局限性

  • 5%(70/1538)患者在30天失访,22%(336/1538)患者在1年失访。
  • 未来研究应通过使用STTGMA创伤风险评分作为控制混杂因素或随机试验比较标准化与个体化外科医生特异性护理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many initiatives by medical and public health communities at the national, state, and institutional level have been centered around understanding and analyzing critical determinants of population health with the goal of equitable and nondisparate care. In orthopaedic traumatology, several studies have demonstrated that race and socioeconomic status are associated with differences in care delivery and outcomes of patients with hip fractures. However, studies assessing the effectiveness of methods to address disparities in care delivery, quality metrics, and complications after hip fracture surgery are lacking. QUESTIONS/PURPOSES: (1) Are hospital quality measures (such as delay to surgery, major inpatient complications, intensive care unit admission, and discharge disposition) and outcomes (such as mortality during inpatient stay, within 30 days or within 1 year) similar between White and non-White patients at a single institution in the setting of a standardized hip fracture pathway? (2) What factors correlate with aforementioned hospital quality measures and outcomes under the standardized care pathway? METHODS: In this retrospective, comparative study, we evaluated the records of 1824 patients 55 years of age or older with hip fractures from a low-energy mechanism who were treated at one of four hospitals in our urban academic healthcare system, which includes an orthopaedic tertiary care hospital, from the initiation of a standardized care pathway in October 2014 to March 2020. The standardized 4-day hip fracture pathway is comprised of medicine comanagement of all patients and delineated tasks for doctors, nursing, social work, care managers, and physical and occupational therapy from admission to expected discharge on postoperative day 4. Of the 1824 patients, 98% (1787 of 1824) of patients who had their race recorded in the electronic medical record chart (either by communicating it to a medical provider or by selecting their race from options including White, Black, Hispanic, and Asian in a patient portal of the electronic medical record) were potentially eligible. A total of 14% (249 of 1787) of patients were excluded because they did not have an in-state address. Of the included patients, 5% (70 of 1538) were lost to follow-up at 30 days and 22% (336 of 1538) were lost to follow-up at 1 year. Two groups were established by including all patients selecting White as primary race into the White cohort and all other patients in the non-White cohort. There were 1111 White patients who were 72% (801) female with mean age 82 ± 10 years and 427 non-White patients who were 64% (271) female with mean age 80 ± 11 years. Univariate chi-square and Mann-Whitney U tests of demographics were used to compare White and non-White patients and find factors to control for potentially relevant confounding variables. Multivariable regression analyses were used to control for important baseline between-group differences to (1) determine the correlation of White and non-White race on mortality, inpatient complications, intensive care unit (ICU) admissions, and discharge disposition and (2) assess the correlation of gender, socioeconomic status, insurance payor, and the Score for Trauma Triage in the Geriatric and Middle Aged (STTGMA) trauma risk score with these quality measures and outcomes. RESULTS: After controlling for gender, insurer, socioeconomic status and STTGMA trauma risk score, we found that non-White patients had similar or improved care in terms of mortality and rates of delayed surgery, ICU admission, major complications, and discharge location in the setting of the standardized care pathway. Non-White race was not associated with inpatient (odds ratio 1.1 [95% CI 0.40 to 2.73]; p > 0.99), 30-day (OR 1.0 [95% CI 0.48 to 1.83]; p > 0.99) or 1-year mortality (OR 0.9 [95% CI 0.57 to 1.33]; p > 0.99). Non-White race was not associated with delay to surgery beyond 2 days (OR = 1.1 [95% CI 0.79 to 1.38]; p > 0.99). Non-White race was associated with less frequent ICU admissions (OR 0.6 [95% CI 0.42 to 0.85]; p = 0.03) and fewer major complications (OR 0.5 [95% CI 0.35 to 0.83]; p = 0.047). Non-White race was not associated with discharge to skilled nursing facility (OR 1.0 [95% CI 0.78 to 1.30]; p > 0.99), acute rehabilitation facility (OR 1.0 [95% CI 0.66 to 1.41]; p > 0.99), or home (OR 0.9 [95% CI 0.68 to 1.29]; p > 0.99). Controlled factors other than White versus non-White race were associated with mortality, discharge location, ICU admission, and major complication rate. Notably, the STTGMA trauma risk score was correlated with all endpoints. CONCLUSION: In the context of a hip fracture care pathway that reduces variability from time of presentation through discharge, no differences in mortality, time to surgery, complications, and discharge disposition rates were observed beween White and non-White patients after controlling for baseline differences including trauma risk score. The pathway detailed in this study is one iteration that the authors encourage surgeons to customize and trial at their institutions, with the goal of providing equitable care to patients with hip fractures and reducing healthcare disparities. Future investigations should aim to elucidate the impact of standardized trauma care pathways through the use of the STTGMA trauma risk score as a controlled confounder or randomized trials in comparing standardized to individualized, surgeon-specific care. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Parola R, Neal WH, Konda SR, et al. No Differences Between White and Non-White Patients in Terms of Care Quality Metrics, Complications, and Death After Hip Fracture Surgery When Standardized Care Pathways Are Used. Clin Orthop Relat Res. 2022. PMID: 35238810. doi:10.1097/CORR.0000000000002142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。